Effect of Cholesterol Molecules on Aβ1-42 Wild-Type and Mutants Trimers

Molecules. 2022 Feb 18;27(4):1395. doi: 10.3390/molecules27041395.

Abstract

Alzheimer's disease displays aggregates of the amyloid-beta (Aβ) peptide in the brain, and there is increasing evidence that cholesterol may contribute to the pathogenesis of the disease. Though many experimental and theoretical studies have focused on the interactions of Aβ oligomers with membrane models containing cholesterol, an understanding of the effect of free cholesterol on small Aβ42 oligomers is not fully established. To address this question, we report on replica exchange with a solute tempering simulation of an Aβ42 trimer with cholesterol and compare it with a previous replica exchange molecular dynamics simulation. We show that the binding hot spots of cholesterol are rather complex, involving hydrophobic residues L17-F20 and L30-M35 with a non-negligible contribution of loop residues D22-K28 and N-terminus residues. We also examine the effects of cholesterol on the trimers of the disease-causing A21G and disease-protective A2T mutations by molecular dynamics simulations. We show that these two mutations moderately impact cholesterol-binding modes. In our REST2 simulations, we find that cholesterol is rarely inserted into aggregates but rather attached as dimers and trimers at the surface of Aβ42 oligomers. We propose that cholesterol acts as a glue to speed up the formation of larger aggregates; this provides a mechanistic link between cholesterol and Alzheimer's disease.

Keywords: aggregation; amyloid-beta; cholesterol; mutants; simulations.

MeSH terms

  • Amino Acid Sequence
  • Amyloid beta-Peptides / chemistry*
  • Cholesterol / chemistry*
  • Cholesterol / pharmacology
  • Hydrogen-Ion Concentration
  • Molecular Conformation
  • Molecular Docking Simulation
  • Molecular Dynamics Simulation
  • Mutant Proteins / chemistry*
  • Peptide Fragments / chemistry*
  • Protein Aggregates
  • Protein Aggregation, Pathological
  • Protein Binding
  • Protein Multimerization* / drug effects
  • Structure-Activity Relationship

Substances

  • Amyloid beta-Peptides
  • Mutant Proteins
  • Peptide Fragments
  • Protein Aggregates
  • amyloid beta-protein (1-42)
  • Cholesterol